The weak leadership of Bristol-Myers is an underestimated opportunity News ad
Bristol-Myers Squibb Marketrank ™ Analysis of Reserves General market ™ 95th percentile Analyst rating Hold Breaking/disadvantage 0.5% disadvantage Short level of interest Healthy The power of dividends Strong Environmental assessment -2.30 Mood news 1.02 Insider trade N/a Professe Earnings growth 663.04% See full analysis Stock Bristol-Myers Squibb NYSE: BmyThey are trying to return to a … Read more
